These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5095787)

  • 1. Increase in fine motor control in Parkinson patients following levodopa.
    Marsh GG; Kravitz EA
    Percept Mot Skills; 1971 Aug; 33(1):211-5. PubMed ID: 5095787
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease: L-dopa treatment and handwriting area.
    Knopp W; Paulson G; Allen JN; Smeltzer D; Brown FD; Kose W
    Curr Ther Res Clin Exp; 1970 Mar; 12(3):115-25. PubMed ID: 4985489
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of a previous thalamotomy on the L-dopa effects on mono-manual dexterity in parkinsonism.
    Knutsson E; Mårtensson A; Meyerson BA; Risberg AM
    Scand J Rehabil Med; 1973; 5(3):130-3. PubMed ID: 4754551
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychomotor performances of patients undergoing L-dopa therapy.
    Davis LJ; Muenter MD
    Percept Mot Skills; 1971 Dec; 33(3):1303-8. PubMed ID: 5160051
    [No Abstract]   [Full Text] [Related]  

  • 5. Observations on patients with Parkinson's disease treated with L-dopa. I. Trial and evaluation of L-dopa therapy.
    van Wieringen A; Wright J
    S Afr Med J; 1972 Sep; 46(35):1262-6. PubMed ID: 4638222
    [No Abstract]   [Full Text] [Related]  

  • 6. Physostigmine in choreiform movement disorders.
    Tarsy D; Leopold N; Sax DS
    Neurology; 1974 Jan; 24(1):28-33. PubMed ID: 4358998
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-range motor performance changes in levodopa-treated patients with Parkinson's disease.
    Birdsong JH; McKinney AS
    Neurology; 1974 Feb; 24(2):107-15. PubMed ID: 4855677
    [No Abstract]   [Full Text] [Related]  

  • 8. L-dopa: effect on highest integrative functions in Parkinsonism.
    Guthrie TC; Dunbar HS; Weider A
    Trans Am Neurol Assoc; 1970; 95():250-2. PubMed ID: 5514382
    [No Abstract]   [Full Text] [Related]  

  • 9. A double-blind study of the effects of levodopa in Parkinson's disease.
    Nakano KK; Tyler HR
    Neurology; 1971 Oct; 21(10):1069-74. PubMed ID: 4939556
    [No Abstract]   [Full Text] [Related]  

  • 10. Levodopa in parkinsonism.
    Practitioner; 1972 May; 208(247):695-9. PubMed ID: 4560973
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative effects of L-dopa on different types of movements and muscle tone in Parkinsonian patients.
    Knutsson E; Mårtensson A
    Scand J Rehabil Med; 1971; 3(3):121-30. PubMed ID: 5156174
    [No Abstract]   [Full Text] [Related]  

  • 12. Some quantitative behavioral changes in L-dopa therapy.
    Meier MJ; Baker AB; Martin WE
    Geriatrics; 1972 Jun; 27(6):89-97. PubMed ID: 5032486
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study of L-dopa in Parkinson's disease].
    Franken L; Noel G; Lhoas JP; Meyers C; Noel P; Ectors M
    Brux Med; 1972 Dec; 52(12):851-60. PubMed ID: 4575350
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversal by levodopa of cholinergic hypersensitivity in Parkinson's disease.
    Weintraub MI; Van Woert MH
    N Engl J Med; 1971 Feb; 284(8):412-5. PubMed ID: 5540479
    [No Abstract]   [Full Text] [Related]  

  • 15. The modifying influence of L-dopa on the physical therapy program in Parkinson's disease.
    Blonsky ER; Minnigh EC
    Prog Phys Ther; 1970; 1(1):55-74. PubMed ID: 5523796
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term therapy of Parkinson's disease with amantadine, alone and combined with levodopa.
    Zeldowicz LR; Hubermann J
    Can Med Assoc J; 1973 Oct; 109(7):588-93. PubMed ID: 4582563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of Parkinson's disease with levodopa].
    Sigwald J; Raymondeaud C; Grégoire J
    Therapeutique; 1972 Nov; 48(9):543-54. PubMed ID: 4650524
    [No Abstract]   [Full Text] [Related]  

  • 18. Some quantitative behavioural changes in L-dopa therapy.
    Meier MJ; Baker AB; Martin WE
    Trans Am Neurol Assoc; 1970; 95():64-8. PubMed ID: 5514413
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical use of levodopa in the treatment of Parkinson's disease.
    McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD
    Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056
    [No Abstract]   [Full Text] [Related]  

  • 20. [The Rey complex picture test in evaluation of some effects induced by treatment with L-dopa in patients with parkinsonism].
    Megna GF; Puca FM; Micalizzi V; Leggiadro N; Di Rosa AE
    Acta Neurol (Napoli); 1971; 26(4):473-83. PubMed ID: 4943712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.